Psyence Biomedical Ltd. Common Shares (PBM) — Financial Flexibility Index
Psyence Biomedical Ltd. Common Shares (PBM) has a Financial Flexibility Index of -0.05x as of December 2023. Free cash flow of $-658.20 (operating CF $-662.00 minus capex $3.80) represents 0% of total liabilities ($12.10K). Check Psyence Biomedical Ltd. Common Shares (PBM) strategic investment index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Psyence Biomedical Ltd. Common Shares Financial Flexibility Index (2022–2025)
Historical Financial Flexibility Index trend for Psyence Biomedical Ltd. Common Shares across 4 annual periods. See how liquid is Psyence Biomedical Ltd. Common Shares's working capital to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Psyence Biomedical Ltd. Common Shares (2022–2025)
Year-by-year free cash flow to debt coverage for Psyence Biomedical Ltd. Common Shares. For the full company profile including market capitalisation, see Psyence Biomedical Ltd. Common Shares market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -6.27x | $-3.72 Million | $-3.73 Million | $594.37K | ▼ -2480.2% |
| 2024 | -0.24x | $-2.94 Million | $-2.95 Million | $12.10 Million | ▼ -567.0% |
| 2023 | -0.04x | $-519.60K | $-519.60K | $14.27 Million | ▲ +57.3% |
| 2022 | -0.09x | $-1.40 Million | $-1.40 Million | $16.38 Million | — |